Showing results (1351-1360 of 1,493) with videos related to
Sort By:
Pageof 150
The Science of the Total Environment|March 22, 2022
Ceramide metabolism mediates the impaired glucose homeostasis following short-term black carbon exposure: A targeted lipidomic analysisYifan Xu, Xi Chen, Yiqun Han, et al.Journal of Magnetic Resonance Imaging : JMRI|October 15, 2013
Liver dynamic contrast-enhanced MRI for staging liver fibrosis in a piglet modelLi Zhou, Tian-wu Chen, Xiao-ming Zhang, et al.Environmental Research, Health : ERH|November 29, 2023
Critical windows of greenness exposure during preconception and gestational periods in association with birthweight outcomesZhenchun Yang, Jiawen Liao, Yi Zhang, et al.Environmental Research, Health : ERH|July 11, 2026
Wearable measured physiological stress and activity patterns changes after 2025 Los Angeles wildfire among older adults: findings from a pilot prospective cohort studyJiawen Liao, Ruoxue Chen, Rui Tian, et al.The International Journal of Biochemistry & Cell Biology|January 30, 2022
WDR62 regulates mouse oocyte meiotic maturation related to p-JNK and H3K9 trimethylationYong-Sheng Wang, Chao Chen, Muhammad Jamil Ahmad, et al.Elife|January 3, 2023
Antisense oligonucleotide therapy rescues disturbed brain rhythms and sleep in juvenile and adult mouse models of Angelman syndromeDongwon Lee, Wu Chen, Heet Naresh Kaku, et al.Investigational New Drugs|March 3, 2019
A phase I study of pexidartinib, a colony-stimulating factor 1 receptor inhibitor, in Asian patients with advanced solid tumorsJih-Hsiang Lee, Tom Wei-Wu Chen, Chih-Hung Hsu, et al.Chemico-Biological Interactions|September 29, 2022
Bromoacetic acid impairs mouse oocyte in vitro maturation through affecting cytoskeleton architecture and epigenetic modificationYong-Sheng Wang, Li-Dan Zhang, Xv Zhou, et al.National Science Review|May 1, 2023
Hologenomic insights into mammalian adaptations to myrmecophagyShao-Chen Cheng, Chun-Bing Liu, Xue-Qin Yao, et al.Journal of Medicinal Chemistry|April 10, 2019
Discovery and Characterization of XY101, a Potent, Selective, and Orally Bioavailable RORγ Inverse Agonist for Treatment of Castration-Resistant Prostate CancerYan Zhang, Xishan Wu, Xiaoqian Xue, et al.Pageof 150